In vivo analysis of these subcutaneous xenografts confirmed the in vitro findings, showing that PAQR5 knockdown significantly inhibited tumor growth compared to the vehicle control group (P < 0.05, Fig. 7A–C). This evidence concerns the gene PAQR5 and neoplasm.